Skip to main content
Fig. 3 | BMC Neurology

Fig. 3

From: A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson's disease

Fig. 3

Continuous glucose monitor (CGM) results over 7 inpatient days for representative participants on a standard diet (top 2 plots, average/daily) and on a ketogenic diet (bottom 2 plots, average/daily). The top single line plot for each representative participant indicates mean glucose values, and the bottom multiple line plot shows each day’s values

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us